NORWOOD, Mass., Dec. 14, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (MRMD) (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every ...
Q1 2026 Management View "Last night, we reported first quarter 2026 revenue of $39.5 million and positive adjusted EBITDA of $3.6 million. Additionally, we once again generated positive cash flow from ...
NORWOOD, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- MariMed, Inc. (CSE: MRMD), (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis ...
NORWOOD, Mass., April 30, 2024 (GLOBE NEWSWIRE) -- The following is a statement from Jon Levine, CEO and President of leading multi-state cannabis operator, MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX ...
Jon Levine, CEO, highlighted a sixth consecutive year of positive adjusted EBITDA and emphasized the company's 1% revenue growth in 2025, stating "2025 also marked the sixth consecutive year we ...
NORWOOD, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Following today’s announcement that Delaware will commence adult-use sales of cannabis, MariMed CEO Jon Levine released the following statement: “We ...
MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results